| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $206.0M | +1566.8% |
| R&D Expense | $147.8M | -15.0% |
| SG&A Expense | $46.1M | +11.1% |
| Operating Income | $12.2M | +106.0% |
| Pre-tax Income | $10.6M | +105.2% |
| Income Tax | $1.3M | — |
| Net Income | $9.3M | +104.6% |
| EPS (Basic) | $0.35 | +104.5% |
| EPS (Diluted) | $0.35 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $391.9M | +5.8% |
| Accounts Receivable | $2.8M | -17.9% |
| Current Assets | $403.3M | +6.4% |
| Total Assets | $450.4M | +14.7% |
| Current Liabilities | $127.0M | +27.6% |
| Long-term Debt | $40.6M | +165.6% |
| Total Liabilities | $180.1M | +9.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $32.0M | +123.7% |
| Capital Expenditures | $7.7M | +126.8% |
| Investing Cash Flow | -$7.7M | -126.8% |
| Financing Cash Flow | -$2.9M | -106.0% |
| Free Cash Flow | $24.3M | +117.5% |
| +104.5% |
| Stockholders' Equity |
| $270.3M |
| +18.4% |